CSC
LFCR icon

Cove Street Capital’s Lifecore Biomedical LFCR Stock Holding History

Cove Street Capital’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$5 – 101
2024
Q3 		$5 Sell
1
-2,824
-100% -$14.8K ﹤0.01% 99
2024
Q2 		$14K Sell
2,825
-1,280,955
-100% -$7.59M 0.01% 67
2024
Q1 		$6.82M Buy
1,283,780
+373,516
+41% +$2.67M 2.16% 19
2023
Q4 		$5.63M Sell
910,264
-195,292
-18% -$1.36M 1.72% 25
2023
Q3 		$7.47M Sell
1,105,556
-513,980
-32% -$4.7M 2.53% 15
2023
Q2 		$15.7M Sell
1,619,536
-264,808
-14% -$1.62M 4.86% 4
2023
Q1 		$7.11M Sell
1,884,344
-61,850
-3% -$345K 2.12% 17
2022
Q4 		$12.6M Buy
1,946,194
+57,700
+3% +$476K 3.44% 7
2022
Q3 		$16.8M Sell
1,888,494
-32,927
-2% -$335K 4.69% 5
2022
Q2 		$19.2M Buy
1,921,421
+49,540
+3% +$491K 4.83% 4
2022
Q1 		$21.7M Buy
1,871,881
+75,517
+4% +$841K 3.83% 6
2021
Q4 		$19.9M Sell
1,796,364
-17,189
-0.9% -$167K 3.49% 6
2021
Q3 		$16.7M Buy
1,813,553
+21,009
+1% +$229K 2.48% 13
2021
Q2 		$20.2M Buy
1,792,544
+113,406
+7% +$1.31M 2.92% 10
2021
Q1 		$17.8M Buy
1,679,138
+559,733
+50% +$6.29M 2.55% 15
2020
Q4 		$12.1M Buy
1,119,405
+459,223
+70% +$4.74M 2.15% 19
2020
Q3 		$6.42M Buy
660,182
+589,942
+840% +$5.62M 1.21% 30
2020
Q2 		$559K Buy
70,240
+30,240
+76% +$312K 0.11% 59
2020
Q1 		$348K Buy
+40,000
New +$416K 0.07% 76

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cove Street Capital's LFCR Position: Q4 2024 in Review

Cove Street Capital sold out of Lifecore Biomedical (LFCR) in Q4 2024, closing a stake of 1 share — an estimated $5 sold.

Cove Street Capital first reported a position in LFCR in Q1 2020 and held it in 19 quarters. The position peaked at $21.7M in Q1 2022. 77 funds tracked by Wall St. Rank hold LFCR as of Q4 2024.

  • Cove Street Capital reported no remaining Lifecore Biomedical position as of Q4 2024 after selling out during the quarter.
  • Cove Street Capital sold 1 Lifecore Biomedical share in Q4 2024, an estimated $5.
  • Cove Street Capital first reported a position in Lifecore Biomedical in Q1 2020 and held it in 19 quarters.
  • Cove Street Capital's Lifecore Biomedical position peaked at $21.7M in Q1 2022.
  • 77 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2024.

Based on Cove Street Capital's 13F filing for Q4 2024, filed 12 Feb 2025.